Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Cellebrite DI (CLBT) Invested Capital: 2020-2025

Historic Invested Capital for Cellebrite DI (CLBT) over the last 5 years, with Sep 2025 value amounting to $834.3 million.

  • Cellebrite DI's Invested Capital rose 32.59% to $834.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $834.3 million, marking a year-over-year increase of 32.59%. This contributed to the annual value of $336.0 million for FY2024, which is 882.17% up from last year.
  • According to the latest figures from Q3 2025, Cellebrite DI's Invested Capital is $834.3 million, which was up 5.96% from $787.4 million recorded in Q2 2025.
  • In the past 5 years, Cellebrite DI's Invested Capital registered a high of $207.6 billion during Q2 2024, and its lowest value of -$130.0 million during Q3 2021.
  • Its 3-year average for Invested Capital is $19.3 billion, with a median of $529.1 million in 2024.
  • As far as peak fluctuations go, Cellebrite DI's Invested Capital plummeted by 214.96% in 2021, and later soared by 206,794,344.56% in 2024.
  • Quarterly analysis of 5 years shows Cellebrite DI's Invested Capital stood at -$73.3 million in 2021, then soared by 200.71% to $73.9 million in 2022, then tumbled by 53.68% to $34.2 million in 2023, then spiked by 882.17% to $336.0 million in 2024, then surged by 32.59% to $834.3 million in 2025.
  • Its Invested Capital stands at $834.3 million for Q3 2025, versus $787.4 million for Q2 2025 and $709.9 million for Q1 2025.